[1] |
FANG Zhie, LI Chengxian, BAI Zhaofang, ZHAO Xu, WANG Jiabo, XIAO Xiaohe.
Investigation of objectivity in the relationship between aristolochic acid and hepatocellular carcinoma
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 20-24.
|
[2] |
YUAN Sisi, WANG Guangyan, LI Yifan, LI Ruilian, DU Boran, FENG Xin.
Safety-related risk factors in clinical management of narcotics and psychotropic substances via failure mode and effect analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1027-1030.
|
[3] |
ZHANG Qingxia, ZHOU Liujun, LI Xiaoling, WANG Yuqin.
Cefoperazone/sulbactam-related medication errors in the elderly and countermeasures
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 574-578.
|
[4] |
ZHANG Qingxia, JIANG Yongxian, LI Gen, YAN Suying, WANG Yuqin.
Analysis and prevention of medication errors related to stored pharmaceuticals in National Monitoring Network for Clinical Safety Medication
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1040-1044.
|
[5] |
CHU Yanqi, JIANG Yongxian, SHEN Jianghua, XING Xiaoxuan, ZHANG Qingxia, YAN Suying.
Analgesia-related risks after thoracoscopic surgery in elderly patients
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1023-1026.
|
[6] |
ZHANG Qingxia, JIANG Yongxian, DONG Yuexin, XIAN Ying, YAN Suying.
Risk analysis and precautions related to storage conditions specified in package inserts of western medicines in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 913-918.
|
[7] |
SHAO Chen, ZHANG Qingxia, YAN Suying, WANG Yuqin.
Analysis of 1028 statins-related medication errors and prevention strategies
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 645-648.
|
[8] |
ZHANG Qingxia, DING Qian, YAN Suying, WANG Yuqin.
Analysis and prevention of medication errors of dabigatran etexilate and rivaroxaban
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(12): 1372-1375.
|
[9] |
ZHANG Qingxia, JIANG Yongxian, DONG Yuexin, XIAN Ying, WANG Yuqin, YAN Suying.
Risk investigation of insulin storage and analysis and prevention of typical insulin-related medication errors
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1242-1245.
|
[10] |
GAO Yunjuan, ZHAO Xu, BAI Zhaofang, WANG Jiabo, ZHAN Xiaoyan, GUO Yuming, XIAO Xiaohe.
Prevention and Control of Safety Risks of Traditional Chinese Medicine Based on Indirect Knowledge of Toxicity
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1004-1008.
|
[11] |
CHEN Feng.
Latest Development of International Pharmacovigilance and Its Implications
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 867-870.
|
[12] |
LIU Chen, CHU Yanqi, YAN Suying, JIN Chao, LIU Tong, XING Liqiu, ZHANG Xiao.
Analysis of 93 Reports of Adverse Drug Reactions Induced by Edaravone Injection
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 174-178.
|
[13] |
LI Lan, XIA Dong-sheng, TIAN Chun-hua.
Misuse Risk Analysis of Methotrexate and Enlightenment to Pharmacovigilance
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(9): 538-540.
|
[14] |
QI Xian-fang , ZHANG Long, CHEN Xiao-meng, SUN Jun.
Analysis of Medication Errors in a Tertiary General Hospital
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(12): 760-763.
|
[15] |
ZHUANG, Hong-yan, HAO Hong-bing, LIU Shan-shan, GUO Wei, MA Xin, LI Hua-wei, CHI Wei, ZHANG Hong-yu.
Analysis of Psychiatric Medication Error Reports of 69 Cases
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(1): 54-58.
|